𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical potential of chemokine receptor antagonists

✍ Scribed by Sofia Ribeiro; Richard Horuk

Book ID
113845607
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
225 KB
Volume
107
Category
Article
ISSN
0163-7258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic potential of the chemokine r
Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents
✍ Hiroshi Tsutsumi; Tomohiro Tanaka; Nami Ohashi; Hiroyuki Masuno; Hirokazu Tamamu πŸ“‚ Article πŸ“… 2007 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 200 KB πŸ‘ 1 views

## Abstract The chemokine receptor CXCR4 possesses multiple critical functions in normal and pathologic physiology. CXCR4 is a G‐protein‐coupled receptor that transduces signals of its endogenous ligand, the chemokine CXCL12 (stromal cell‐derived factor‐1, SDF‐1). The interaction between CXCL12 and

Emerging new chemokine CXCR3 antagonists
Emerging new chemokine CXCR3 antagonists and their potential clinical and therapeutic applications
✍ Shailendra Kapoor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 1 views

hospitalized in urban teaching centers (52% versus 41%; P Ο½ 0.0001). ALI and liver failure 7 occurred in 8.2% and 4.5% of patients, respectively; 1.4% died. ALI (16.7% versus 8.0%; P Ο½ 0.0001), liver failure (11.4% versus 4.4%; P Ο½ 0.0001), and death (3.0% versus 1.4%; P Ο­ 0.01), but not transplanta